Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors
Publication
, Conference
Lemons, JM; Chmura, SJ; Luke, JJ; Salama, JK; Al-Hallaq, HA
Published in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
October 1, 2016
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
October 1, 2016
Volume
96
Issue
2
Start / End Page
E631 / E632
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lemons, J. M., Chmura, S. J., Luke, J. J., Salama, J. K., & Al-Hallaq, H. A. (2016). Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 96, pp. E631–E632).
Lemons, J. M., S. J. Chmura, J. J. Luke, J. K. Salama, and H. A. Al-Hallaq. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96:E631–32, 2016.
Lemons JM, Chmura SJ, Luke JJ, Salama JK, Al-Hallaq HA. Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2016. p. E631–2.
Lemons, J. M., et al. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 96, no. 2, 2016, pp. E631–32.
Lemons JM, Chmura SJ, Luke JJ, Salama JK, Al-Hallaq HA. Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2016. p. E631–E632.
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
October 1, 2016
Volume
96
Issue
2
Start / End Page
E631 / E632
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences